News GSK hits back in 5-in-1 meningitis jab contest with Pfizer Phase 3 trial sets up filing for GSK's MenABCWY vaccine, several months later than its rival.
News Rumour of Pfizer, Seagen deal is true, with $43bn price tag Pfizer says Seagen's current and future drugs could add $10 billion to its revenues from 2030.
News Pfizer’s migraine push builds with Zavzpret nod Zavzpret is first CGRP to be approved in a nasal formulation designed to be rapid acting.
News Pfizer’s Susan Rienow named new president of ABPI Appointment follows the exit of Novo Nordisk's Pinder Sahota, after firm's ABPI code breaches.
News FDA removes leash from Verzenio in early breast cancer Drug can now be used as adjuvant therapy without Ki-67 testing, taking a brake off prescribing.
News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
